Safety
Safety information
Your safety comes first. Review important information about our treatments before you begin, and always follow the guidance of your prescribing provider.
Boxed warnings
Compounded Semaglutide (GLP-1)
Boxed warning — risk of thyroid C-cell tumors. In rodent studies, semaglutide caused thyroid C-cell tumors. It is not known whether it causes such tumors, including medullary thyroid carcinoma (MTC), in humans. Do not use if you or a family member have had MTC or have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Read full safety information →Compounded Tirzepatide (GLP-1/GIP)
Boxed warning — risk of thyroid C-cell tumors. In rodent studies, tirzepatide caused thyroid C-cell tumors. It is not known whether it causes such tumors, including medullary thyroid carcinoma (MTC), in humans. Do not use if you or a family member have had MTC or have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Read full safety information →Safety by compound
Completing an assessment on this site does not create a doctor-patient relationship and does not guarantee treatment. Diadara is not a healthcare provider; it is a technology platform that connects you with independent licensed providers and pharmacies. Treatment is only provided when prescribed by a licensed provider. Compounded medications are prepared by licensed US pharmacies on a valid prescription and are not reviewed or approved by the FDA for safety or effectiveness.
This page is general educational information, not medical advice, and is not a complete list of risks. Your prescribing provider will review your full history. Report side effects to your provider; you may also report to the FDA at 1-800-FDA-1088.